Germany

Archimedes Pharma Germany markets a portfolio of products to specialist prescribers in the areas of pain, oncology, critical care and Parkinson’s disease. This expertise underpins the commercial potential for the recent launch in Germany of the transformational product for Archimedes, PecFent^® (fentanyl pectin nasal spray), an innovative nasal spray aimed at managing breakthrough pain in cancer.

Key products marketed in Germany include:

• PecFent^® (fentanyl pectin nasal spray). View the SmPC
• Gliadel^® implant (carmustine). View the SmPC
• Oramorph^® oral solution (morphine sulphate) View the SmPC
• Apomorphine injection (apomorphine HCl). View the SmPC